1st Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
lobbied on issues related to non-biologic complex drugs (NBCD), abuse-deterrent formulation of drugs, prescription drug abuse, FDA proposed rule on generic drug labeling. monitored SGR legislation as it related to payfors in the pharmaceutical drug space.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.